US Patent Issued to Janssen Pharmaceutica on Sept. 15 for "Treatment of prostate cancer with a combination of abiraterone acetate, niraparib tosylate monohydrate and prednisone" (Belgian, Dutch, American Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,180, issued on Sept. 15, was assigned to Janssen Pharmaceutica NV (Beerse, Belgium).

"Treatment of prostate cancer with a combination of abiraterone acetate, niraparib tosylate monohydrate and prednisone" was invented by Thomas Ronald A. Quinten (Zeveneken, Belgium), Urbain Alfons C. Delaet (Balen, Belgium), Philip Erna H. Heyns (Vosselaar, Belgium), Tatiana Marcozzi (Borgerhout, Belgium), Johny Bertels (Mol, Belgium), Katrien Luyten (Oud-Turnhout, Belgium), Kaustubh Ramesh Tambwekar (Geel, Belgium), Angela Lopez-Gitlitz (Los Angeles) and Paul J. A. Hartman Kok (Eersel, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosu...